Tonix Advances Novel Oxytocin Treatment for Prader-Willi Syndrome into Clinical Testing
- November 23, 2025
Semaglutide Shows Liver Health Benefits Beyond Weight Loss in MASH Patients
ATTR Gene Therapy Shows Durable Benefit Despite Safety Concerns
Mezagitamab Demonstrates Lasting Kidney Protection 18 Months After Final Dose in IgA Nephropathy
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Tonix Advances Novel Oxytocin Treatment for Prader-Willi Syndrome into Clinical Testing bit.ly/4hXMo51 Read now at PatientWorthy.com
#PatientWorthy #Prader-WilliSyndrome #clinicaltrials
@UVA @CharcotMArieToothAssociationCMTA is proud to welcome Dr. Francesco Michelassi and the UVA Health Neuromuscular Team in Charlottesville, VA, as our newest CMTA Center of Excellence. 🌟
Dr. Michelassi is a physician-scientist specializing in a wide range of neuromuscular disorders, including Charcot-Marie-Tooth disease, peripheral neuropathy, muscular dystrophy, spinal muscular atrophy, and inclusion body myositis. Born and raised in Hyde Park, Chicago, he brings exceptional clinical insight, research expertise, and heartfelt dedication to families living with CMT. 💙
🔗 Learn more at cmtausa.org/simply-cmt/uva-coe/
@PDSA"The intent in clinical research is really to answer a research question through volunteers, and the intent really is to help people in the future." — Dr. Rachael Grace
Clinical trials sound intimidating, but what if they’re actually a path to better options? In Episode 27 of Bruised but Not Broken: Living with ITP, Dr. Rachael Grace joins host Barbara Pruitt to demystify clinical trials, explaining how they differ from standard treatments, when they might be the right choice, and how they’ve already shaped major advancements in ITP care.
🔗 Listen now: pdsa.org/podcast or on Apple and Spotify
#ITP #ITPpodcast #ITPresearch #ClinincalTrial #Hematology #PatientEducation #LivingWithITP #ITPtreatment #LowPlatelets #PlateletDisorder #BloodDisorder
